Akso Health Group Sponsored ADR (NASDAQ:AHG) Sees Large Decline in Short Interest

Key Points

• Short interest in Akso Health Group fell sharply by 25.1% in April to 28,640 shares (from 38,262 on March 31), with a days-to-cover of just 0.2 and effectively 0.0% of shares sold short.
• Shares opened at $2.33, trading near a 50‑day simple moving average of $2.00 and a 200‑day SMA of $1.68, with a 52‑week range of $1.07 to $2.50.
• Hedge fund SmartHarvest boosted its stake by 111.5% to 35,429 shares (about $81,000), institutional ownership stands at 1.21%, and Weiss Ratings reaffirmed a Sell (D-) rating, with the consensus rating on MarketBeat listed as "Sell".

Akso Health Group Sponsored ADR (NASDAQ:AHG - Get Free Report) saw a significant decrease in short interest in April. As of April 15th, there was short interest totaling 28,640 shares, a decrease of 25.1% from the March 31st total of 38,262 shares. Based on an average daily volume of 151,959 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the shares of the company are sold short.

Akso Health Group Stock Performance

Shares of Akso Health Group stock opened at $2.33 on Wednesday. The business has a fifty day simple moving average of $2.00 and a 200-day simple moving average of $1.68. Akso Health Group has a fifty-two week low of $1.07 and a fifty-two week high of $2.50.

Institutional Trading of Akso Health Group

A hedge fund recently raised its stake in Akso Health Group stock. SmartHarvest Portfolios LLC increased its position in Akso Health Group Sponsored ADR (NASDAQ:AHG - Free Report) by 111.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,429 shares of the company's stock after buying an additional 18,681 shares during the quarter. SmartHarvest Portfolios LLC's holdings in Akso Health Group were worth $81,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 1.21% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of Akso Health Group in a research note on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of "Sell".

About Akso Health Group

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.